Hall, Rasheeda K.
Kazancıoğlu, Rümeyza http://orcid.org/0000-0003-1217-588X
Thanachayanont, Teerawat
Wong, Germaine
Sabanayagam, Dharshana
Battistella, Marisa
Ahmed, Sofia B. http://orcid.org/0000-0003-3000-2229
Inker, Lesley A.
Barreto, Erin F.
Fu, Edouard L.
Clase, Catherine M.
Carrero, Juan J. http://orcid.org/0000-0003-4763-2024
Article History
Accepted: 22 February 2024
First Online: 15 March 2024
Competing interests
: R.K. has received honoraria from Baxter. L.A.I. has received funding Omeros, Chinook Therapeutics, R3R and Travere Pharmaceuticals for research and contracts to Tufts Medical Center, and has consulted for Diamerix. E.F.B. has received funding from Numares, and has consulted for Wolters Kluwer. C.M.C. has received consultation, advisory board membership, honoraria or research funding from Sanofi, Pfizer, Leo Pharma, Astellas, Janssen, Amgen, Boehringer-Ingelheim, Baxter and, through the Liv Academy, AstraZeneca. She is editor-in-chief of the <i>Canadian Journal of Kidney Health and Disease</i>. J.J.C. has received support from AstraZeneca, ViforPharma, Novonordisk, Astellas, MSD, GSK, Boehringer Ingelheim and Amgen, outside the scope of this work; he has also received lecture fees from Baxter, Fresenius Kabi, AstraZeneca, Astellas, GSK and Abbott, and has participated in advisory boards for AstraZeneca, Nestle and Bayer. The other authors do not declare any conflicts of interest.